Metagenomi

Biotechnology

Preclinical biotechnology company. Uses metagenomics-based genome editing to develop therapeutic therapies, has analyzed over 460 trillion base pairs and predicted over 7.4 billion proteins, targeting indications in the liver, neuromuscular and other organs, with all product candidates being preclinical .

_____________________________

The number of employees:

200-250

_____________________________

Headquarters:

1545 Park Avenue Emeryville, California 94608, USA